Heart failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, based on pronounced alterations in αII spectrin regulation in human heart failure we tested the <i>in vivo</i> roles of αII spectrin in the vertebrate heart.
|
31064843 |
2019 |
Congestive heart failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, based on pronounced alterations in αII spectrin regulation in human heart failure we tested the <i>in vivo</i> roles of αII spectrin in the vertebrate heart.
|
31064843 |
2019 |
nervous system disorder
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Furthermore, human αII spectrin loss-of-function variants cause neurological disease.
|
31064843 |
2019 |
Henoch-Schoenlein Purpura
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our results further suggest that SPTAN1 may cause autosomal recessive HSP, and that it should be included in genetic screening panels for genetically undiagnosed HSP patients.
|
31515523 |
2019 |
Tumor Progression
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
To investigate the link between MLH1 and SPTAN1 in cancer progression, a cohort of 189 patients with CRC was analyzed by immunohistochemistry.
|
30856214 |
2019 |
Peripheral motor neuropathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Nonsense mutations in alpha-II spectrin in three families with juvenile onset hereditary motor neuropathy.
|
31332438 |
2019 |
Autosomal Recessive Hereditary Spastic Paraplegia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
SPTAN1 variants as a potential cause for autosomal recessive hereditary spastic paraplegia.
|
31515523 |
2019 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.
|
30856214 |
2019 |
Congenital Abnormality
|
0.010 |
Biomarker
|
group |
BEFREE |
One may speculate that a deficiency in αII-spectrin plays an important role not only in the DNA repair defect but also in the congenital anomalies observed in Fanconi anemia , particularly since αII-spectrin has been shown to be important in embryonic development in a mouse model.
|
29557213 |
2018 |
Myoclonic Epilepsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This patient is the second reported case with 9q33.3-q34.11 deletion involving STXBP1 and SPTAN1 genes associated with epileptic encephalopathy and myoclonic seizures.
|
29897043 |
2018 |
Subarachnoid Hemorrhage
|
0.010 |
Biomarker
|
disease |
BEFREE |
Evaluation of alpha-II-spectrin breakdown products as potential biomarkers for early recognition and severity of aneurysmal subarachnoid hemorrhage.
|
30190542 |
2018 |
Thyroid Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Moreover, both children have abnormal thyroid function, which has not been previously reported in association with SPTAN1 variant.
|
30548380 |
2018 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Such investigations should help unravel the complexities of αII-spectrin's interactions with other nuclear proteins and enhance our understanding of the pathogenesis of disorders, such as Fanconi anemia , in which there is a deficiency in αII-spectrin.
|
29557213 |
2018 |
Myoclonic Seizures
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
This patient is the second reported case with 9q33.3-q34.11 deletion involving STXBP1 and SPTAN1 genes associated with epileptic encephalopathy and myoclonic seizures.
|
29897043 |
2018 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, this report is the first to identify a fusion involving CSF3R and SPTAN1 in aCML with t(1;9)(p34;q34).
|
29025591 |
2017 |
Microcephaly
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The major clinical features of SPTAN1 mutations include epileptic encephalopathy with hypsarrhythmia, no visual attention, acquired microcephaly, spastic quadriplegia and severe intellectual disability.
|
25631096 |
2015 |
Early myoclonic encephalopathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Early myoclonic encephalopathy in 9q33-q34 deletion encompassing STXBP1 and SPTAN1.
|
25779878 |
2015 |
Malignant tumor of colon
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Nine cancer cell lines as well as fresh and paraffin embedded colon cancer tissue from 12 patients were used in gene expression studies of SPTAN1 and MLH1.
|
24456667 |
2014 |
Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Nine cancer cell lines as well as fresh and paraffin embedded colon cancer tissue from 12 patients were used in gene expression studies of SPTAN1 and MLH1.
|
24456667 |
2014 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Further, a prophage gene, STM2699, induced in cold-stressed Salmonella and a spectrin gene, SPTAN1, induced in Salmonella-infected intestinal epithelial cells were found to have a significant contribution in increased adhesion and invasion of cold-stressed Salmonella in epithelial cells.
|
25192993 |
2014 |
Leukemia, T-Cell
|
0.010 |
Biomarker
|
disease |
BEFREE |
Among the identified 17 classifier proteins, α-II spectrin was drastically accumulated in infected T cells derived from ATL patients, whereas its digestive protease calpain-2 (CAN2) was significantly downregulated.
|
23538341 |
2013 |
Adult T-Cell Lymphoma/Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Among the identified 17 classifier proteins, α-II spectrin was drastically accumulated in infected T cells derived from ATL patients, whereas its digestive protease calpain-2 (CAN2) was significantly downregulated.
|
23538341 |
2013 |
Tuberculosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study suggests the possible role of decreased levels of αII-spectrin in the pathology of tuberculosis.
|
24055022 |
2013 |
Intellectual Disability
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy.
|
22258530 |
2012 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the early stage, initial response to self-antigens (LF, CA-II, CA-IV, PSTI, or α-fodrin) or molecular mimicry (Helicobacter pylori) is induced by decreased naive regulatory T cells (Tregs), and Th1 cells release proinflammatory cytokines (IFN-γ, IL-1b, IL-2, and TNF-α).
|
20862490 |
2010 |